Opto Circuits launches automated external defibrillator in US and Canada

Cardiac Science, Opto Circuits India Ltd’s group company, has unveiled its automated external defibrillator (AED) in the US and Canada, representing a technological milestone in the AED industry and high anticipation from its loyal customers. 

The Powerheart G5 is the first FDA-cleared AED to combine fully automatic shock delivery, dual-language functionality, variable escalating energy, and fast shock times to help save a sudden cardiac arrest (SCA) victim‘s life. SCA is the leading cause of death globally with 17.3 million deaths each year, according to the American Heart Association. 

“The North American AED market has yearned for an AED of this technology, scope, and importance. We have seen the impact of this product when we launched it in Europe back in 2012: immediate market share, adoption, and demand,” said Vinod Ramnani, chairman and managing director, Opto Circuits India Ltd.

Along with its sister AED, the Powerheart G3, the Powerheart G5 is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered SCA, a condition in which the heart suddenly stops beating due to irregularities in its electrical system. 

“As more and more countries recognise the threat posed by SCA, legislation and public attitudes are steering buying decisions. This, in turn, has allowed our company to maintain price-points as customers want AEDs that our easy to use, ready for operation, and feature advanced technology,” added Ramnani.